Literature DB >> 3511447

Thymine glycol lesions terminate chain elongation by DNA polymerase I in vitro.

J M Clark, G P Beardsley.   

Abstract

Single-strand circular DNA from bacteriophage M13mp9 was chemically modified with osmium tetroxide to introduce specifically cis-thymine glycol lesions, a major type of DNA damage produced by ionizing radiation. An oligonucleotide primer was extended on damaged and undamaged templates using either the large fragment of E. coli pol I or T4 DNA polymerase. The reaction products were analysed by electrophoresis alongside a DNA sequence ladder. Synthesis on the damaged templates terminated at positions opposite thymine bases in the template. These results indicate that cis-thymine glycol lesions in single-strand DNA constitute blocks to synthesis by DNA polymerases in vitro. Surprisingly, replication halts after the correct nucleotide, dAMP, is inserted opposite the lesion. These results imply that the primary effect of the thymine glycol lesion is suppression of DNA synthesis and that the lesion is not a potent mutagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511447      PMCID: PMC339461          DOI: 10.1093/nar/14.2.737

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  DNA repair enzymes.

Authors:  T Lindahl
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

2.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Two types of replication proteins increase the rate at which T4 DNA polymerase traverses the helical regions in a single-stranded DNA template.

Authors:  C C Huang; J E Hearst; B M Alberts
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Radiation-induced degradation of the base component in DNA and related substances--final products.

Authors:  R Teoule; J Cadet
Journal:  Mol Biol Biochem Biophys       Date:  1978

6.  Sites of termination of in vitro DNA synthesis on ultraviolet- and N-acetylaminofluorene-treated phi X174 templates by prokaryotic and eukaryotic DNA polymerases.

Authors:  P D Moore; K K Bose; S D Rabkin; B S Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

7.  Monoclonal antibody to DNA containing thymine glycol.

Authors:  S A Leadon; P C Hanawalt
Journal:  Mutat Res       Date:  1983-08       Impact factor: 2.433

8.  Termination sites of the in vitro nick-translation reaction on DNA that had photoreacted with psoralen.

Authors:  J G Piette; J E Hearst
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Effect of acetylated and deacetylated 2-aminofluorene adducts on in vitro DNA synthesis.

Authors:  P D Moore; S D Rabkin; A L Osborn; C M King; B S Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  39 in total

1.  Mitochondrial genetics: principles and practice.

Authors:  J M Shoffner; D C Wallace
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

2.  Synthesis and thermodynamic studies of oligodeoxyribonucleotides containing tandem lesions of thymidine glycol and 8-oxo-2'-deoxyguanosine.

Authors:  Yuesong Wang; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

3.  RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors.

Authors:  Nicolas Charlet-Berguerand; Sascha Feuerhahn; Stephanie E Kong; Howard Ziserman; Joan W Conaway; Ronald Conaway; Jean Marc Egly
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

4.  Germ-line variant of human NTH1 DNA glycosylase induces genomic instability and cellular transformation.

Authors:  Heather A Galick; Scott Kathe; Minmin Liu; Susan Robey-Bond; Dawit Kidane; Susan S Wallace; Joann B Sweasy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

5.  Characterization of endonuclease III (nth) and endonuclease VIII (nei) mutants of Escherichia coli K-12.

Authors:  Y Saito; F Uraki; S Nakajima; A Asaeda; K Ono; K Kubo; K Yamamoto
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

6.  Non-specific DNA binding interferes with the efficient excision of oxidative lesions from chromatin by the human DNA glycosylase, NEIL1.

Authors:  Ian D Odell; Kheng Newick; Nicholas H Heintz; Susan S Wallace; David S Pederson
Journal:  DNA Repair (Amst)       Date:  2009-12-11

7.  The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.

Authors:  Yun Huang; William A Pastor; Yinghua Shen; Mamta Tahiliani; David R Liu; Anjana Rao
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

8.  Interconversion of the cis-5R,6S- and trans-5R,6R-thymine glycol lesions in duplex DNA.

Authors:  Kyle L Brown; Travis Adams; Vijay P Jasti; Ashis K Basu; Michael P Stone
Journal:  J Am Chem Soc       Date:  2008-08-06       Impact factor: 15.419

9.  Processing of thymine glycol in a clustered DNA damage site: mutagenic or cytotoxic.

Authors:  Sophie Bellon; Naoya Shikazono; Siobhan Cunniffe; Martine Lomax; Peter O'Neill
Journal:  Nucleic Acids Res       Date:  2009-05-25       Impact factor: 16.971

10.  Binding of the human nucleotide excision repair proteins XPA and XPC/HR23B to the 5R-thymine glycol lesion and structure of the cis-(5R,6S) thymine glycol epimer in the 5'-GTgG-3' sequence: destabilization of two base pairs at the lesion site.

Authors:  Kyle L Brown; Marina Roginskaya; Yue Zou; Alvin Altamirano; Ashis K Basu; Michael P Stone
Journal:  Nucleic Acids Res       Date:  2009-11-05       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.